Fundraising Fox

Adarza BioSystems

St. Peters, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

RR
Randolph R. HenkeFounder
BW
Bryan WitherbeeExecutive
LM
Linda MeehExecutive
CS
Christopher StriemerExecutive
TG
Teryl GronwallExecutive
BM
Benjamin MillerNamed on SEC filing

Board

JS
Jay SchmelterBoard director
JR
Jenny RookeBoard director
SB
Scott BernsteinBoard director
JM
John McKearn, Ph.D.Board director
DS
David SmollerBoard director
HD
Heiner DreismannBoard director

Investors · 1

Hemisphere Ventures LLCMckinney

Reported raises · per SEC filings

Form D private placements

$30.5M disclosed across 4 rounds · 2014–2019

▶$12.8MraisedFeb 2020 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • BRYAN WITHERBEEExecutive Officer, Director
  • LARRY PAGEDirector
  • JOHN MCKEARNDirector
  • BENJAMIN MILLERDirector
  • JENNY ROOKEDirector
  • JAY SCHMELTERDirector
  • DAVID SMOLLERDirector
Offering amount
$26.6M
Amount sold
$12.8M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.9MraisedJan 2018 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bryan WitherbeeExecutive Officer, Director
  • Jay SchmelterDirector
  • Jenny RookeDirector
  • David SmollerDirector
  • Linda MeehExecutive Officer
  • Scott BernsteinDirector
  • Benjamin MillerDirector
  • John McKearn, Ph.D.Director
Offering amount
$17M
Amount sold
$10.9M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.9MraisedMar 2016 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew JayDirector
  • David SmollerDirector
  • Benjamin MillerDirector
  • Christopher StriemerExecutive Officer
  • Heiner DreismannDirector
  • Randolph R. HenkeExecutive Officer, Director, Promoter
Offering amount
$7M
Amount sold
$4.9M
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJul 2014 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SmollerDirector
  • Heiner DreismannDirector
  • Christopher StriemerExecutive Officer
  • Randolph R. HenkeExecutive Officer, Director, Promoter
  • Teryl GronwallExecutive Officer
  • Benjamin MillerDirector
Offering amount
$2M
Amount sold
$2M
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Adarza BioSystems Raises Another $25 Million to Launch Platform for Research and Drug Development | EQentrepreneurquarterly.com · Feb 2020Adarza BioSystems Raises $25 Million in Series D Funding Round | GenomeWebgenomeweb.com · Feb 2020Adarza BioSystems Closes on $17 Million - What's Next for the Life Science Startup | EQentrepreneurquarterly.com · Jan 2017Adarza BioSystems Closes $17M Series C Financing - FinSMEsfinsmes.com · Jan 2017Adarza Biosystems Bags $17 Million Series C - BioSpacebiospace.com · Jan 2017Adarza BioSystems raises $6.8 million - Rochester Business Journalrbj.net · Oct 2014

Frequently asked questions

Who founded Adarza BioSystems?
Adarza BioSystems was founded by Randolph R. Henke.
Who are Adarza BioSystems's investors?
Adarza BioSystems's investors include Hemisphere Ventures LLC.
How much funding has Adarza BioSystems raised?
Adarza BioSystems has disclosed $30.5M raised across 4 rounds.
Where is Adarza BioSystems headquartered?
Adarza BioSystems is headquartered in St. Peters, US.